Acetazolamide Injection, Powder, Lyophilized, For Solution
Product Images NDC 39822-0190

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 39822-0190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xgen Pharmaceuticals Djb, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C:\documents And Settings\junem.x-gen.000\desktop\desktop Work\spl Submissions\acetazolamide Spl\01.jpg (Acetazolamide For Injection Usp 1)

The provided text appears to be a chemical formula consisting of the elements hydrogen, nitrogen, oxygen, carbon, and sulfur. The molecular weight of the compound is given as 222.24 g/mol. However, it is impossible to determine the name or properties of the compound based on this limited information.*

FDA Label Image

Da2fae20-figure-02 (Acetazolamide For Injection Usp 2)

FDA Label Image

Da2fae20-figure-03 (Acetazolamide For Injection Usp 3)

FDA Label Image

Acetazolamide For Injection Usp 4

AcetaZOLAMIDE for Injection, USP is a medication usually dosed as instructed in the package insert. Each vial contains acetazamide socium, the equivalent of 500mg acetazolamide, and should be reconstituted. The pH is adjusted to 9.6 with sodium hydroxide, and hydrochloric acid may be added if needed. The reconstituted solution must be used within 12 hours and refrigerated at 2-8°C (36-46°F). Discard any unused portion. There are no preservatives in this medication. The provided text also includes product codes and storage instructions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.